Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6832
Rank
NZ$1.03 B
Marketcap
NZ$51.86
Share price
0.43%
Change (1 day)
-15.52%
Change (1 year)

Financial Statements

Thumbnail Avalon Pharma (Middle East Pharmaceutical) Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement